Table 2 Demographic and clinical data of patients included in the validation phase of the study.

From: Tear proteome analysis in ocular surface diseases using label-free LC-MS/MS and multiplexed-microarray biomarker validation

Group

n

Gender (M/F)

Age

OSDI

TBUT

Schirmer I test

Fluorescein staining

CT

9

3/6

36.78 ± 20.41

2.39 ± 2.45

13.39 ± 5.97

18.06 ± 5.85

0.33 ± 0.50

DE

24

10/14

54.58 ± 21.55

35.92 ± 19.37

6.21 ± 3.51

5.58 ± 5.30

1.50 ± 1.25

  1. CT = Control; DE = Dry eye.
Back to article page